↓ Skip to main content

A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19

Overview of attention for article published in Frontiers in Medicine, September 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19
Published in
Frontiers in Medicine, September 2022
DOI 10.3389/fmed.2022.956123
Pubmed ID
Authors

Adeola Fowotade, Folasade Bamidele, Boluwatife Egbetola, Adeniyi F. Fagbamigbe, Babatunde A. Adeagbo, Bolanle O. Adefuye, Ajibola Olagunoye, Temitope O. Ojo, Akindele O. Adebiyi, Omobolanle I. Olagunju, Olabode T. Ladipo, Abdulafeez Akinloye, Adedeji Onayade, Oluseye O. Bolaji, Steve Rannard, Christian Happi, Andrew Owen, Adeniyi Olagunju

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 40%
Lecturer > Senior Lecturer 1 10%
Student > Master 1 10%
Unknown 4 40%
Readers by discipline Count As %
Nursing and Health Professions 1 10%
Chemistry 1 10%
Medicine and Dentistry 1 10%
Engineering 1 10%
Unknown 6 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 September 2022.
All research outputs
#8,115,819
of 24,506,807 outputs
Outputs from Frontiers in Medicine
#2,048
of 6,687 outputs
Outputs of similar age
#148,149
of 422,872 outputs
Outputs of similar age from Frontiers in Medicine
#123
of 502 outputs
Altmetric has tracked 24,506,807 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 6,687 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.9. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 422,872 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 502 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.